Vladimir R. Muzykantov

Overview

Best Publications

• Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities

  Zhiliang Cheng;Ajlan Al Zaki;James Z. Hui;Vladimir R. Muzykantov

  1393
  Citations

• Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.

  Silvia Muro;Carmen Garnacho;Julie A Champion;John Leferovich

  658
  Citations

• Targeting vascular (endothelial) dysfunction

  Andreas Daiber;Sebastian Steven;Alina Weber;Vladimir V. Shuvaev

  503
  Citations

• Drug delivery by red blood cells: vascular carriers designed by mother nature

  Vladimir R. Muzykantov

  454
  Citations

• Endothelial NADPH Oxidase as the Source of Oxidants in Lungs Exposed to Ischemia or High K

  Abu B. Al-Mehdi;Guochang Zhao;Chandra Dodia;Kasumi Tozawa

  391
  Citations

• A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1

  Silvia Muro;Rainer Wiewrodt;Anu Thomas;Lauren Koniaris

  365
  Citations

• Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

  Carlos H. Villa;Aaron C. Anselmo;Samir Mitragotri;Vladimir Muzykantov

  356
  Citations

• Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.

  Aaron C. Anselmo;Vivek Gupta;Blaine J. Zern;Daniel Pan

  349
  Citations

• Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

  Jacob S. Brenner;Daniel C. Pan;Jacob W. Myerson;Oscar A. Marcos-Contreras

  342
  Citations

• European contribution to the study of ROS : a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

  Javier Egea;Isabel Fabregat;Yves M Frapart;Pietro Ghezzi

  327
  Citations

• The shape of things to come: importance of design in nanotechnology for drug delivery

  Yaling Liu;Jifu Tan;Antony Thomas;Daniel Ou-Yang

  278
  Citations

• Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species.

  Caryn Vadseth;Jose M. Souza;Leonor Thomson;Amy Seagraves

  276
  Citations

• 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage.

  Yefim Manevich;Tom Sweitzer;Jhang Ho Pak;Sheldon I. Feinstein

  263
  Citations

• Targeting of superoxide dismutase and catalase to vascular endothelium.

  Vladimir R Muzykantov

  249
  Citations

• Polymeric carriers: role of geometry in drug delivery.

  Eric A Simone;Thomas D Dziubla;Vladimir R Muzykantov

  238
  Citations

• Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes.

  Juan-Carlos Murciano;Sandra Medinilla;Donald Eslin;Elena Atochina

  235
  Citations

• Advanced drug delivery systems that target the vascular endothelium.

  Bi-Sen Ding;Thomas Dziubla;Vladimir V Shuvaev;Silvia Muro

  235
  Citations

• Distribution of Type I, III, IV and V Collagen in Normal and Atherosclerotic Human Arterial Wall: Immunomorphological Characteristics

  Boris V. Shekhonin;Sergey P. Domogatsky;Vladimir R. Muzykantov;Grigory L. Idelson

  226
  Citations

• Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1

  Silvia Muro;Thomas Dziubla;Weining Qiu;John Leferovich

  225
  Citations

• Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.

  Vladimir R. Muzykantov;Melpo Christofidou-Solomidou;Irina Balyasnikova;Irina Balyasnikova;David W. Harshaw

  207
  Citations